Candriam Equities L Biotech.I USD Acc/ LU0133360163 /
NAV2024-03-27 | Chg.+73.0400 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
5,691.0000USD | +1.30% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2010 | - | - | - | -1.92 | -12.43 | -5.63 | 3.72 | -0.39 | 10.81 | 2.77 | -2.49 | 6.27 | - |
2011 | -0.55 | 0.81 | 6.01 | 4.63 | 3.03 | -1.68 | -3.48 | -7.93 | -6.61 | 8.03 | 0.79 | 1.88 | +3.71% |
2012 | 11.93 | 0.47 | 5.85 | 0.64 | -2.06 | 5.60 | 2.44 | 2.00 | 5.23 | -5.87 | 4.49 | -0.94 | +32.74% |
2013 | 9.77 | 1.10 | 8.17 | 6.20 | 3.38 | -2.67 | 14.37 | -2.34 | 10.05 | -2.71 | 6.63 | 1.70 | +66.35% |
2014 | 8.34 | 7.43 | -9.86 | -5.01 | 2.85 | 10.21 | -3.16 | 11.16 | -1.01 | 9.50 | 2.94 | 0.54 | +36.44% |
2015 | 4.81 | 4.62 | 1.96 | -5.03 | 10.84 | 0.64 | 4.25 | -10.88 | -11.30 | 7.89 | 3.41 | 0.49 | +9.42% |
2016 | -23.19 | -4.51 | 3.72 | 3.59 | 5.36 | -8.22 | 12.56 | -2.43 | 3.84 | -12.36 | 8.72 | -2.84 | -19.55% |
2017 | 5.49 | 6.87 | -0.10 | 1.21 | -3.07 | 9.20 | 2.54 | 6.37 | 0.79 | -6.35 | 0.27 | 1.51 | +26.45% |
2018 | 6.86 | -4.68 | -1.91 | -3.10 | 4.66 | 0.96 | 4.81 | 4.27 | -2.01 | -13.94 | 4.21 | -8.55 | -10.16% |
2019 | 13.26 | 3.44 | -0.55 | -4.85 | -4.71 | 9.40 | -2.30 | -2.34 | -4.19 | 10.49 | 11.81 | 2.45 | +33.72% |
2020 | -5.13 | -1.12 | -4.98 | 12.87 | 9.33 | 1.41 | -2.75 | 0.93 | 0.67 | -2.80 | 9.83 | 3.11 | +21.31% |
2021 | 1.89 | -2.52 | -4.20 | 2.80 | -2.19 | 6.44 | -1.38 | 3.98 | -4.16 | 0.24 | -4.30 | 2.46 | -1.64% |
2022 | -10.78 | -1.97 | 5.73 | -7.56 | -3.34 | 3.06 | 4.62 | 1.14 | -1.89 | 6.92 | 6.13 | -2.78 | -2.50% |
2023 | 3.00 | -5.68 | 0.44 | 2.28 | -1.20 | 1.25 | -0.14 | -0.16 | -4.29 | -6.12 | 5.98 | 13.49 | +7.55% |
2024 | 1.34 | 1.36 | 0.37 | - | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 15.71% | 18.56% | 15.98% | 20.16% | 22.83% |
Sharpe ratio | 0.64 | 1.67 | 0.75 | 0.03 | 0.21 |
Best month | +13.49% | +13.49% | +13.49% | +13.49% | +13.49% |
Worst month | +0.37% | -6.12% | -6.12% | -10.78% | -10.78% |
Maximum loss | -5.04% | -8.67% | -15.09% | -29.30% | -30.63% |
Outperformance | -1.08% | - | -1.94% | +3.07% | +0.98% |
All quotes in USD
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotech.V US... | reinvestment | 2,079.8999 | +16.10% | +14.33% | |
Candriam Equities L Biotech.C EU... | reinvestment | 223.2200 | +15.38% | - | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,088.9299 | +13.38% | +6.42% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,242.2400 | +15.59% | +23.90% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,455.9900 | +12.71% | +22.95% | |
Candriam Equities L Biotech.R GB... | reinvestment | 363.6200 | +13.59% | +27.14% | |
Candriam Equities L Biotech.R EU... | reinvestment | 328.9000 | +16.46% | +26.76% | |
Candriam Equities L Biotech.R CH... | reinvestment | 204.8800 | +11.72% | +5.39% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,865.6000 | +17.18% | +17.47% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 151.9100 | - | - | |
Candriam Equities L Biotech.V US... | reinvestment | 607.9500 | +15.44% | +12.33% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,691.0000 | +15.96% | +13.91% | |
Candriam Equities L Biotech.C EU... | reinvestment | 200.5700 | +14.03% | +6.23% | |
Candriam Equities L Biotech.R US... | reinvestment | 270.5100 | +16.88% | +16.59% | |
Candriam Equities L Biotech.R EU... | reinvestment | 208.8800 | +14.35% | +8.84% | |
Candriam Equities L Biotech.C US... | reinvestment | 852.9000 | +15.86% | +13.77% | |
Candriam Equities L Biotech.C US... | paying dividend | 783.5000 | +15.82% | +13.66% |
Performance
YTD | +3.09% | ||
---|---|---|---|
6 Months | +15.98% | ||
1 Year | +15.96% | ||
3 Years | +13.91% | ||
5 Years | +51.98% | ||
Since start | +469.10% | ||
Year | |||
2023 | +7.55% | ||
2022 | -2.50% | ||
2021 | -1.64% | ||
2020 | +21.31% | ||
2019 | +33.72% | ||
2018 | -10.16% | ||
2017 | +26.45% | ||
2016 | -19.55% | ||
2015 | +9.42% |